DFTX SG&A Expense Growth
Definium Therapeutics Inc · SG&A Expense Growth
DFTX SG&A Expense Growth
Latest reported25.96%period ending
DFTX FY SG&A Growth (YoY) (0.00% → 25.96%)
Latest values, visible window
High-resolution chart · PNG
DFTX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.9587% | |
| -7.4817% | |
| 38.3927% | |
| -48.9342% | |
| 310.2021% | |
| 3,020.0366% | |
| -46.0398% | |
| -30.4455% | |
| 1,005.2646% | |
| 17.661% | |
| 0% |